Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

GLSI

Greenwich LifeSciences Inc

Dec 13 • 04:00PM ET

13.51

Dollar change +0.30
Percentage change 2.27	%

Healthcare • Biotechnology • USA • NASD

Peers: JNJ LLY MRNA AZN PFE REGN GSK BMY BNTX NVAX

| Held by: IWM VTI VXF IWO VTWO IWC VTWG RSSL UWM URTY

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.81	Insider Own	54.94%	Shs Outstand	13.14M	Perf Week	-1.10%
Market Cap	181.61M	Forward P/E	-	EPS next Y	-	Insider Trans	2.63%	Shs Float	5.92M	Perf Month	1.20%
Income	-10.50M	PEG	-	EPS next Q	-	Inst Own	9.34%	Short Float	8.28%	Perf Quarter	-6.44%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	12.90%	Short Ratio	17.27	Perf Half Y	-8.47%
Book/sh	0.38	P/B	35.64	EPS next Y	-	ROA	-140.17%	Short Interest	0.49M	Perf Year	27.33%
Cash/sh	0.43	P/C	31.20	EPS next 5Y	-	ROE	-151.72%	52W Range	8.00 - 21.44	Perf YTD	28.42%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-36.91%	ROI	-210.64%	52W High	-36.99%	Beta	3.25
Dividend TTM	-	Quick Ratio	6.91	Sales past 5Y	0.00%	Gross Margin	-	52W Low	68.88%	ATR (14)	0.77
Dividend Ex-Date	-	Current Ratio	6.91	EPS Y/Y TTM	-16.04%	Oper. Margin	-	RSI (14)	48.43	Volatility	4.20% 6.51%
Employees	7	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	38.00
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	-9.08%	Payout	-	Rel Volume	0.91	Prev Close	13.21
Sales Surprise	-	EPS Surprise	0.00%	Sales Q/Q	-	Earnings	Nov 11	Avg Volume	28.39K	Price	13.51
SMA20	-0.30%	SMA50	-1.00%	SMA200	-7.98%	Trades		Volume	25,916	Change	2.27%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-01-21	Initiated	H.C. Wainwright	Buy	$78

Nov-26-24 06:00AM	Greenwich LifeSciences Partners with GIM in Italy (GlobeNewswire)
Nov-18-24 06:00AM	Greenwich LifeSciences Provides Update on Corporate Events (GlobeNewswire)
Aug-01-24 06:00AM	Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain (GlobeNewswire)
Jun-26-24 07:33AM	Greenwich LifeSciences Set to Join Russell 2000 Index Again (GlobeNewswire) +11.18%
Jun-17-24 09:00AM	Insider Buying: CEO and CFO Snehal Patel Acquires Shares of Greenwich LifeSciences Inc (GLSI) (GuruFocus.com) +18.16%
06:00AM	Loading…
Jun-14-24 06:00AM	Greenwich LifeSciences Announces $2.5 Million Private Placement (GlobeNewswire)
May-20-24 09:53PM	GLSI Stock Earnings: Greenwich LifeSciences Beats EPS for Q1 2024 (InvestorPlace) -6.44%
Apr-15-24 10:53PM	GLSI Stock Earnings: Greenwich LifeSciences Misses EPS for Q4 2023 (InvestorPlace) -8.88%
Apr-10-24 03:30PM	Insiders are Piling into These 10 Healthcare Stocks in 2024 (Insider Monkey)
Mar-13-24 06:00AM	Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025 (GlobeNewswire)
Mar-12-24 06:00AM	Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe (GlobeNewswire) +8.20%
Mar-07-24 09:00AM	Greenwich LifeSciences Inc (GLSI) CEO and CFO, 10% Owner Snehal Patel Acquires Additional Shares (GuruFocus.com) +19.93%
Feb-27-24 06:00AM	Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries (GlobeNewswire)
Feb-22-24 06:00AM	Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators (GlobeNewswire)
Feb-14-24 06:00AM	Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01 (GlobeNewswire) +22.74%
06:00AM	Loading…
Nov-21-23 06:00AM	Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024 (GlobeNewswire)
Sep-13-23 05:02PM	Insider Buying: Snehal Patel Acquires 1,000 Shares of Greenwich LifeSciences Inc (GuruFocus.com)
Jul-26-23 01:12PM	Daily Vickers Top Buyers & Sellers for 07/26/2023 (Argus Research)
Jul-18-23 06:53AM	Daily Vickers Top Buyers & Sellers for 07/18/2023 (Argus Research)
May-10-23 06:32AM	Daily Vickers Top Insider Picks for 05/10/2023 (Argus Research)
May-09-23 06:40AM	Daily Vickers Top Insider Picks for 05/09/2023 (Argus Research)
May-08-23 06:41AM	Daily Vickers Top Insider Picks for 05/08/2023 (Argus Research)
May-05-23 06:58AM	Daily Vickers Top Insider Picks for 05/05/2023 (Argus Research)
May-04-23 06:29AM	Daily Vickers Top Insider Picks for 05/04/2023 (Argus Research)
May-03-23 06:46AM	Daily Vickers Top Insider Picks for 05/03/2023 (Argus Research) +5.02%
May-02-23 06:46AM	Daily Vickers Top Insider Picks for 05/02/2023 (Argus Research)
May-01-23 06:45AM	Daily Vickers Top Insider Picks for 05/01/2023 (Argus Research) +5.88%
Apr-28-23 07:04AM	Daily Vickers Top Insider Picks for 04/28/2023 (Argus Research)
Apr-27-23 06:47AM	Daily Vickers Top Insider Picks for 04/27/2023 (Argus Research)
Apr-26-23 06:26AM	Daily Vickers Top Insider Picks for 04/26/2023 (Argus Research)
07:03AM	Loading…
Apr-20-23 07:03AM	Daily Vickers Top Insider Picks for 04/20/2023 (Argus Research)
Apr-19-23 06:53AM	Daily Vickers Top Insider Picks for 04/19/2023 (Argus Research)
Apr-17-23 06:54AM	Daily Vickers Top Insider Picks for 04/17/2023 (Argus Research)
Apr-14-23 06:37AM	Daily Vickers Top Insider Picks for 04/14/2023 (Argus Research)
Apr-13-23 06:52AM	Daily Vickers Top Insider Picks for 04/13/2023 (Argus Research)
Apr-12-23 07:07AM	Daily Vickers Top Insider Picks for 04/12/2023 (Argus Research) -5.41%
Apr-11-23 06:58AM	Daily Vickers Top Insider Picks for 04/11/2023 (Argus Research)
Apr-10-23 06:44AM	Daily Vickers Top Insider Picks for 04/10/2023 (Argus Research)
Apr-07-23 07:44AM	Daily Vickers Top Insider Picks for 04/07/2023 (Argus Research)
Apr-06-23 10:37AM	Insiders own 39% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) shares but retail investors control 42% of the company (Simply Wall St.)
07:20AM	Daily Vickers Top Insider Picks for 04/06/2023 (Argus Research)
Apr-05-23 06:11AM	Daily Vickers Top Insider Picks for 04/05/2023 (Argus Research)
Apr-04-23 07:08AM	Daily Vickers Top Insider Picks for 04/04/2023 (Argus Research)
Apr-03-23 06:48AM	Daily Vickers Top Insider Picks for 04/03/2023 (Argus Research)
Mar-31-23 06:36AM	Daily Vickers Top Insider Picks for 03/31/2023 (Argus Research)
Mar-30-23 06:36AM	Daily Vickers Top Insider Picks for 03/30/2023 (Argus Research)
Mar-29-23 06:32AM	Daily Vickers Top Insider Picks for 03/29/2023 (Argus Research) +8.37%
Mar-28-23 06:46AM	Daily Vickers Top Insider Picks for 03/28/2023 (Argus Research) -5.86%
Mar-24-23 06:42AM	Daily Vickers Top Insider Picks for 03/24/2023 (Argus Research)
Mar-23-23 07:01AM	Daily Vickers Top Insider Picks for 03/23/2023 (Argus Research)
Mar-21-23 06:23AM	Daily Vickers Top Insider Picks for 03/21/2023 (Argus Research) +9.36%
Mar-20-23 06:35AM	Daily Vickers Top Insider Picks for 03/20/2023 (Argus Research)
Mar-17-23 06:47AM	Daily Vickers Top Insider Picks for 03/17/2023 (Argus Research)
Mar-16-23 06:51AM	Daily Vickers Top Insider Picks for 03/16/2023 (Argus Research)
Mar-15-23 06:44AM	Daily Vickers Top Insider Picks for 03/15/2023 (Argus Research)
Mar-13-23 06:32AM	Daily Vickers Top Insider Picks for 03/13/2023 (Argus Research) +8.00%
Mar-10-23 07:04AM	Daily Vickers Top Insider Picks for 03/10/2023 (Argus Research) -6.05%
Mar-09-23 06:33AM	Daily Vickers Top Insider Picks for 03/09/2023 (Argus Research) -5.43%
Mar-08-23 06:30AM	Daily Vickers Top Insider Picks for 03/08/2023 (Argus Research)
Mar-07-23 06:34AM	Daily Vickers Top Insider Picks for 03/07/2023 (Argus Research) -5.65%
Mar-06-23 07:22AM	Daily Vickers Top Insider Picks for 03/06/2023 (Argus Research)
Mar-03-23 06:38AM	Daily Vickers Top Insider Picks for 03/03/2023 (Argus Research)
Mar-02-23 06:44AM	Daily Vickers Top Insider Picks for 03/02/2023 (Argus Research) -6.81%
Mar-01-23 06:01AM	Daily Vickers Top Insider Picks for 03/01/2023 (Argus Research)
Feb-28-23 06:43AM	Daily Vickers Top Insider Picks for 02/28/2023 (Argus Research)
Feb-27-23 06:50AM	Daily Vickers Top Insider Picks for 02/27/2023 (Argus Research)
Feb-24-23 07:17AM	Daily Vickers Top Insider Picks for 02/24/2023 (Argus Research) -7.28%
Feb-23-23 07:21AM	Daily Vickers Top Insider Picks for 02/23/2023 (Argus Research)
Feb-22-23 06:56AM	Daily Vickers Top Insider Picks for 02/22/2023 (Argus Research) +5.03%
Feb-21-23 07:35AM	Daily Vickers Top Insider Picks for 02/21/2023 (Argus Research) -8.76%
Feb-17-23 06:27AM	Daily Vickers Top Insider Picks for 02/17/2023 (Argus Research)
Feb-16-23 07:28AM	Daily Vickers Top Insider Picks for 02/16/2023 (Argus Research)
Feb-15-23 07:01AM	Daily Vickers Top Insider Picks for 02/15/2023 (Argus Research)
Feb-14-23 06:23AM	Daily Vickers Top Insider Picks for 02/14/2023 (Argus Research)
Feb-13-23 07:30AM	Daily Vickers Top Insider Picks for 02/13/2023 (Argus Research) -6.58%
Feb-10-23 06:42AM	Daily Vickers Top Insider Picks for 02/10/2023 (Argus Research)
Feb-09-23 06:51AM	Daily Vickers Top Insider Picks for 02/09/2023 (Argus Research)
Feb-08-23 06:45AM	Daily Vickers Top Insider Picks for 02/08/2023 (Argus Research)
Feb-07-23 06:46AM	Daily Vickers Top Insider Picks for 02/07/2023 (Argus Research)
Feb-06-23 06:56AM	Daily Vickers Top Insider Picks for 02/06/2023 (Argus Research)
Feb-03-23 06:32AM	Daily Vickers Top Insider Picks for 02/03/2023 (Argus Research)
Feb-02-23 06:43AM	Daily Vickers Top Insider Picks for 02/02/2023 (Argus Research)
Feb-01-23 06:14AM	Daily Vickers Top Insider Picks for 02/01/2023 (Argus Research)
05:30AM	Companies Like Greenwich LifeSciences (NASDAQ:GLSI) Are In A Position To Invest In Growth (Simply Wall St.)
Jan-31-23 06:50AM	Daily Vickers Top Insider Picks for 01/31/2023 (Argus Research)
Jan-30-23 06:42AM	Daily Vickers Top Insider Picks for 01/30/2023 (Argus Research)
Jan-27-23 07:00AM	Daily Vickers Top Insider Picks for 01/27/2023 (Argus Research)
Jan-26-23 06:44AM	Daily Vickers Top Insider Picks for 01/26/2023 (Argus Research)
Jan-25-23 06:39AM	Daily Vickers Top Insider Picks for 01/25/2023 (Argus Research)
06:39AM	Daily Vickers Top Buyers & Sellers for 01/25/2023 (Argus Research)
Jan-11-23 06:53AM	Daily Vickers Top Buyers & Sellers for 01/11/2023 (Argus Research)
Jan-05-23 05:10AM	Insider Buying: The Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO, CFO & Director Just Bought US$61k Worth Of Shares (Simply Wall St.)
Jan-04-23 06:54AM	Daily Vickers Top Buyers & Sellers for 01/04/2023 (Argus Research)
Dec-29-22 06:51AM	Daily Vickers Top Insider Picks for 12/29/2022 (Argus Research) -9.54%
06:48AM	Greenwich LifeSciences Provides Year End Update (Business Wire)
Dec-28-22 06:58AM	Daily Vickers Top Insider Picks for 12/28/2022 (Argus Research) +9.04%
Dec-27-22 07:11AM	Daily Vickers Top Insider Picks for 12/27/2022 (Argus Research) +6.25%
Dec-23-22 06:32AM	Daily Vickers Top Insider Picks for 12/23/2022 (Argus Research)
Dec-22-22 06:34AM	Daily Vickers Top Insider Picks for 12/22/2022 (Argus Research)
Dec-21-22 09:55AM	After Golden Cross, Greenwich LifeSciences, Inc. (GLSI)'s Technical Outlook is Bright (Zacks) +8.30%

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Thompson Jaye	VP Clinical Reg Affairs	Nov 21 '24	Buy	12.91	1,000	12,910	264,148	Nov 25 06:03 AM
Patel Snehal	CEO and CFO	Sep 26 '24	Buy	14.63	1,500	21,945	5,536,102	Sep 30 06:04 AM
Thompson Jaye	VP Clinical Reg Affairs	Aug 12 '24	Buy	13.85	800	11,080	263,148	Sep 16 06:05 AM
Patel Snehal	CEO and CFO	Aug 06 '24	Buy	13.81	2,000	27,620	5,534,602	Aug 08 06:05 AM
Patel Snehal	CEO and CFO	Aug 05 '24	Buy	13.18	5,500	72,490	5,532,602	Aug 07 06:05 AM
Thompson Jaye	VP Clinical Reg Affairs	Aug 02 '24	Buy	15.15	1,000	15,150	262,348	Aug 05 06:05 AM
Patel Snehal	CEO and CFO	Jul 23 '24	Buy	15.89	1,500	23,835	5,527,102	Jul 24 06:05 AM
Thompson Jaye	VP Clinical Reg Affairs	Jul 18 '24	Buy	16.00	1,000	16,000	261,348	Jul 22 06:05 AM
Patel Snehal	CEO and CFO	Jun 13 '24	Buy	14.30	174,825	2,499,998	5,525,602	Jun 17 06:10 AM
Patel Snehal	CEO and CFO	Apr 01 '24	Buy	19.08	3,000	57,240	5,350,777	Apr 03 06:10 AM
Patel Snehal	CEO and CFO	Mar 22 '24	Buy	19.98	2,500	49,950	5,347,777	Mar 26 06:05 AM
Patel Snehal	CEO and CFO	Mar 20 '24	Buy	17.68	1,500	26,520	5,345,277	Mar 22 06:02 AM
Patel Snehal	CEO and CFO	Mar 05 '24	Buy	12.49	30,500	380,945	5,343,777	Mar 07 06:05 AM
Patel Snehal	CEO and CFO	Mar 04 '24	Buy	13.03	4,100	53,423	5,340,277	Mar 06 06:05 AM
Patel Snehal	CEO and CFO	Feb 16 '24	Buy	11.16	10,800	120,528	5,336,177	Feb 21 06:05 AM
Patel Snehal	CEO and CFO	Feb 15 '24	Buy	11.07	12,700	140,589	5,325,377	Feb 20 06:04 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GLSI

Greenwich LifeSciences Inc

Upgrade your FINVIZ experience